Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZYVERSA THERAPEUTICS INC

0.7080
+0.04306.47%
Volume:115.92K
Turnover:83.13K
Market Cap:1.82M
PE:-0.08
High:0.7400
Open:0.6900
Low:0.6700
Close:0.6650
Loading ...
Jul 07, 2023

Correspondence

Form CORRESP - Correspondence
Jul 07, 2023

Correspondence

Form CORRESP - Correspondence
Jul 07, 2023

Correspondence

Form CORRESP - Correspondence
Jun 30, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 30, 2023

Correspondence

Form CORRESP - Correspondence
Jun 15, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 12, 2023

Major Issues Report

Form 8-K - Current report
May 19, 2023

Major Issues Report

Form 8-K - Current report
May 19, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 12, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 03, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 25, 2023

Correspondence

Form CORRESP - Correspondence
Apr 25, 2023

Correspondence

Form CORRESP - Correspondence
Apr 24, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 24, 2023

Correspondence

Form CORRESP - Correspondence
Apr 24, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence